Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Novartis AG ADR (NYSE: NVS) closed the day trading at $109.91 down -0.56% from the previous closing price of $110.53. In other words, the price has decreased by -$0.56 from its previous closing price. On the day, 2.85 million shares were traded. NVS stock price reached its highest trading level at $110.99 during the session, while it also had its lowest trading level at $109.735.
Ratios:
For a better understanding of NVS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.34 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.57. For the most recent quarter (mrq), Quick Ratio is recorded 0.90 and its Current Ratio is at 1.11. In the meantime, Its Debt-to-Equity ratio is 0.74 whereas as Long-Term Debt/Eq ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on September 11, 2024, Downgraded its rating to Neutral and sets its target price to $130 from $135 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 12 ’24 when Kowalski Robert William bought 6,566 shares for $111.72 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVS now has a Market Capitalization of 221286203392 and an Enterprise Value of 239401926656. As of this moment, Novartis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.82, and their Forward P/E ratio for the next fiscal year is 13.35. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.58. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.43 while its Price-to-Book (P/B) ratio in mrq is 5.07. Its current Enterprise Value per Revenue stands at 4.794 whereas that against EBITDA is 12.185.
Stock Price History:
Over the past 52 weeks, NVS has reached a high of $120.92, while it has fallen to a 52-week low of $92.35. The 50-Day Moving Average of the stock is -5.30%, while the 200-Day Moving Average is calculated to be 3.20%.
Shares Statistics:
Over the past 3-months, NVS traded about 1.05M shares per day on average, while over the past 10 days, NVS traded about 1342360 shares per day. A total of 2.04B shares are outstanding, with a floating share count of 1.96B. Insiders hold about 0.00% of the company’s shares, while institutions hold 7.09% stake in the company. Shares short for NVS as of 1728950400 were 4791122 with a Short Ratio of 4.58, compared to 1726185600 on 5323078. Therefore, it implies a Short% of Shares Outstanding of 4791122 and a Short% of Float of 0.23999999000000002.
Dividends & Splits
NVS’s forward annual dividend rate is 3.74, up from 3.919 a year ago. Against a Trailing Annual Dividend Yield of 0.035456438The stock’s 5-year Average Dividend Yield is 3.61.
